Discover 1,431 paid clinical trials in St. Petersburg, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,431
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
for
Rheumatic Joint Disease
Location: St. Petersburg FL, Orlando FL, Gainesville FL,
Sponsor: Duke University
Sex: All
Age: 0 - 21
Code: NCT02418442
Recruiting
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
for
B-cell Acute Lymphoblastic Leukemia
Location: Saint Petersburg FL, Gainesville FL, Miami FL,
Location: St. Petersburg FL, Orlando FL, Jacksonville FL,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0 - 1
Code: NCT05685745
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage
for
Intraventricular Hemorrhage of Prematurity
Location: St. Petersburg FL, Baltimore MD
Sponsor: Johns Hopkins University
Sex: All
Age: 0
Code: NCT05617833
Phase 1, Recruiting
The Pediatric Anesthesia Quality Improvement Project
for
Surgery, Anesthesia, Children
Location: St Petersburg FL, Orlando FL, Charleston SC, Atlanta GA,
Sponsor: The Society for Pediatric Anesthesia
Sex: All
Age: 0 - 21
Code: NCT00674388
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: St. Petersburg FL, Tampa FL, Orlando FL, Fort Myers FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase 3, Recruiting
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: St. Petersburg FL, Atlanta GA, Memphis TN, Houston TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase 2, Phase 3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. Petersburg FL, Tampa FL, Orlando FL, Fort Myers FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: St. Petersburg FL, Tampa FL, Orlando FL, Fort Myers FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Location: St. Petersburg FL, Tampa FL, Orlando FL, Fort Myers FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase 2, Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: St. Petersburg FL, Orlando FL, Jacksonville FL,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase 2, Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
for
B-cell Acute Lymphoblastic Leukemia,
Location: St. Petersburg FL, Houston TX, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 25
Code: NCT06395103
Phase 1, Phase 2, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: St. Petersburg FL, Tampa FL, Orlando FL, Fort Myers FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase 3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study